Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
0.9100
-0.0718 (-7.31%)
At close: Apr 1, 2025, 4:00 PM
0.9753
+0.0653 (7.17%)
After-hours: Apr 1, 2025, 7:13 PM EDT

Opus Genetics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
--9.9917.89-56.69-24.62
Upgrade
Depreciation & Amortization
-0.01000.01
Upgrade
Other Amortization
----0.94
Upgrade
Asset Writedown & Restructuring Costs
----10.5
Upgrade
Loss (Gain) From Sale of Investments
-0.030.170.07-
Upgrade
Stock-Based Compensation
-3.511.811.911.51
Upgrade
Other Operating Activities
-1.25-35.153.72
Upgrade
Change in Accounts Receivable
-2.52-4.85--
Upgrade
Change in Accounts Payable
-1.08-0.520.380.79
Upgrade
Change in Other Net Operating Assets
-0.48-0.19-0.20.35
Upgrade
Operating Cash Flow
--1.1114.31-19.37-6.8
Upgrade
Capital Expenditures
----0.1-1.48
Upgrade
Cash Acquisitions
----2.01
Upgrade
Investing Cash Flow
----0.10.54
Upgrade
Short-Term Debt Issued
---0.652.2
Upgrade
Total Debt Issued
---0.652.2
Upgrade
Short-Term Debt Repaid
---0.54-0.11-
Upgrade
Total Debt Repaid
---0.54-0.11-
Upgrade
Net Debt Issued (Repaid)
---0.540.542.2
Upgrade
Issuance of Common Stock
-9.264.4628.580.06
Upgrade
Other Financing Activities
--0.28-0.13-1.5118.87
Upgrade
Financing Cash Flow
-8.983.7927.6121.12
Upgrade
Net Cash Flow
-7.8718.18.1414.86
Upgrade
Free Cash Flow
--1.1114.31-19.47-8.27
Upgrade
Free Cash Flow Margin
--5.84%35.92%-3305.60%-
Upgrade
Free Cash Flow Per Share
--0.050.69-1.31-1.77
Upgrade
Cash Interest Paid
--0.010-
Upgrade
Cash Income Tax Paid
-0.34---
Upgrade
Levered Free Cash Flow
-0.247.64-12.29-10.75
Upgrade
Unlevered Free Cash Flow
-1.077.65-12.29-7.41
Upgrade
Change in Net Working Capital
-4.4-4.165.55-0.091.54
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q